K-ras point mutation occurs in the early stage of carcinogenesis in lung cancer

Br J Cancer. 1998 Mar;77(5):720-3. doi: 10.1038/bjc.1998.118.


In order to determine the topographical distribution of the K-ras codon 12 mutations in carcinoma and preneoplastic lesions of the lung, selective ultraviolet radiation fractionation, as well as microdissection followed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RELP), was performed. Fourteen of 61 samples amplified (23.0%) had a mutation in the K-ras codon 12. Of 41 adenocarcinoma, 12 samples (29.3%) had a mutation, whereas none of the squamous cell carcinomas had a mutation. One of six large-cell carcinomas, one of three carcinoid tumours and none of three other carcinomas had a mutation. Direct sequencing revealed that K-ras codon 12 of six samples were TGT (Cys), five samples were GTT (Val), two samples were GCT (Ala) and one sample was TTT (Phe). A total of 113 lesions of 13 cases covered by dot were amplified after UV radiation. All of 74 carcinoma lesions had the mutation, and intratumour heterogeneity was not observed. Of 39 non-malignant lesions, one type II cell hyperplasia had the mutation, which suggests that the K-ras mutation occurs in the early stage of carcinogenesis. The lack of intratumour heterogeneity supports the hypothesis.

Publication types

  • Comparative Study

MeSH terms

  • Adenocarcinoma / genetics*
  • Carcinoid Tumor / genetics*
  • Carcinoma, Large Cell / genetics*
  • Carcinoma, Squamous Cell / genetics*
  • Cell Transformation, Neoplastic / genetics*
  • DNA Mutational Analysis
  • DNA, Neoplasm / genetics
  • Genes, ras*
  • Humans
  • Hyperplasia
  • Lung / pathology
  • Lung Diseases / genetics*
  • Lung Neoplasms / genetics*
  • Point Mutation*
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length
  • Precancerous Conditions / genetics*


  • DNA, Neoplasm